The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...

Cancer research, drug safety testing and aging biology may all gain a major boost from a new fluorescent sensor developed at ...

The Diagnostic Labs Market is poised for growth due to rising chronic disease prevalence, aging populations, and advancements in technology. Key opportunities include leveraging AI for better data ...

Cancer research, drug safety testing and ageing biology may all gain a major boost from a new fluorescent sensor developed at ...

It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues.

Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...

Last winter, for the first time since Covid-19 entered our world, influenza reclaimed its spot as the worst actor among the ...

One of the teams is trying to combine mRNA vaccine with ultrasound technology to treat deadly pancreatic cancer.

A breakthrough live-cell sensor makes DNA repair visible as it happens, unlocking new possibilities in biology and medicine.

IO360º today announced the 2026 sponsoring companies of the 12th annual Immuno-Oncology 360º Summit (IO360°) to date, who provide the capabilities the IO marketplace needs to advance the science.

QuidelOrtho Corporation , a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian Ding, MD, PhD, Senior Medical Affairs Manager, QuidelOrtho, an ...